2022-RA-1557-ESGO Mesenteric lymph node involvement in patients undergoing a bowel resection during debulking surgery in advanced ovarian cancer. (20th October 2022)

• Record Type: Journal Article
• Authors: Galli, Federica; Candotti, Giorgio; Ruffolo, Alessandro; Fais, Maria Luisa; de Marzi, Patrizia; Peiretti, Michele; Erdas, Enrico; Angioni, Stefano; Sabetta, Giulia; Bocciolone, Luca; Candiani, Massimo
• Is Part Of: International journal of gynecological cancer. Volume 32(2022)Supplement 2
• Page Start: A349
• Page End: A349
• Publication Date: 2022-10-20
• Subjects: Generative organs, Female -- Cancer -- Periodicals; 616.99465
• DOI: 10.1136/ijgc-2022-ESGO.744
• Languages: English
• ISSNs: 1048-891X

Abstract

Abstract : Introduction/Background: The aim of this retrospective study was to investigate the incidence of mesenteric lymph node (MLN) involvement in patients undergoing a bowel resection at the time of debulking surgery in advanced ovarian cancer (OC). Methodology: OC patients undergoing rectosigmoid resection during primary debulking surgery or interval debulking surgery were recorded. The characteristics of mesenteric node involvement were evaluated. Results: MLNs were detected in 29/54 patients (54%); the rate of MLN involvement was 61%. A progressive increase in the rate of metastatic MLNs was documented in association with depth of bowel infiltration (p=0.009). A statistic correlation between positive MLN and pelvic lymph nodes (PLN) (p=0.022), aortic lymph nodes (ALN) (p=0.005) was found. Conclusion: OC patients undergoing rectosigmoid resection during debulking surgery revealed metastatic MLN involvement in 61% of cases. Metastatic MLN status is related to PLN and ALN metastases.